About GenoME Diagnostics
GenoME Diagnostics is a company based in Belfast (United Kingdom) founded in 2020. GenoME Diagnostics has raised $2.1 million across 2 funding rounds from investors including Qubis, Deepbridge Capital and Co-Fund NI. The company has 2 employees as of January 31, 2022. GenoME Diagnostics offers products and services including OvaME. GenoME Diagnostics operates in a competitive market with competitors including AOA, Aspira Women's Health, KOKO Medical, VOC Diagnostics and Avant Diagnostics, among others.
- Headquarter Belfast, United Kingdom
- Employees 2 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Genome Diagnostics Ltd
- Date of Incorporation 31 Jan, 2020
- Jurisdiction BELFAST, NORTHERN IRELAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.1 M (USD)
in 2 rounds
-
Latest Funding Round
$1.68 M (USD), Seed
Mar 03, 2023
-
Investors
Qubis
& 2 more
-
Employee Count
2
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GenoME Diagnostics
GenoME Diagnostics offers a comprehensive portfolio of products and services, including OvaME.
Blood test for early and accurate ovarian cancer diagnosis.
Funding Insights of GenoME Diagnostics
GenoME Diagnostics has successfully raised a total of $2.1M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.68 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GenoME Diagnostics
GenoME Diagnostics has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Qubis, Deepbridge Capital and Co-Fund NI.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Qubis is engaged in commercializing academic research from Queen's University.
|
Locked | Locked | Locked | |
|
Deepbridge Capital is focused on tax-efficient investment opportunities.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for GenoME Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GenoME Diagnostics
Investment portfolio details for GenoME Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GenoME Diagnostics
Detailed financials for GenoME Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genome Diagnostics Comparisons
Peer comparison for GenoME Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GenoME Diagnostics
GenoME Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AOA, Aspira Women's Health, KOKO Medical, VOC Diagnostics and Avant Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Business consultancy services are provided for the biopharma industry.
|
|
| Locked | Locked | Locked |
Diagnostic solutions for ovarian cancer risk in women are provided.
|
|
| Locked | Locked | Locked |
Postpartum hemorrhage addressed by catheter-based medical device for women.
|
|
| Locked | Locked | Locked |
Developer of diagnostic solutions to detect ovarian cancer
|
|
| Locked | Locked | Locked |
Microarray technology is utilized for early ovarian cancer detection.
|
Detailed competitors of GenoME Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genome Diagnostics
Complete news archive for GenoME Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GenoME Diagnostics
GenoME Diagnostics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
GenoME Diagnostics is headquartered in Belfast, United Kingdom. It is registered at Belfast, Northern Ireland, United Kingdom.
Shannon Beattie is the current CEO of GenoME Diagnostics.
GenoME Diagnostics is a funded company, having raised a total of $2.1M across 2 funding rounds to date.
As of Jan 31, 2022, the latest employee count at GenoME Diagnostics is 2.
GenoME Diagnostics was established in 2020 in Belfast, United Kingdom. Focus is placed on the biotechnology and diagnostics sector, where an in-vitro blood test known as OvaME is created. Levels of patented DNA methylation markers are measured in blood samples through droplet digital PCR to identify ovarian cancer. Operations center on test development and validation for clinical use.
GenoME Diagnostics's top competitors include Aspira Women's Health, AOA and KOKO Medical.
GenoME Diagnostics offers OvaME.
GenoME Diagnostics has 3 investors. Key investors include Qubis, Deepbridge Capital, and Co-Fund NI.